Tsui, J K <br/><br/>
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease.  [electronic resource] 

 -  Neurology  Jun 1989 
 - 856-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.39.6.856  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Male<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Phenanthridines--adverse effects<br/>Placebos